Marex Group Zukünftiges Wachstum
Future Kriterienprüfungen 2/6
Marex Group's revenue is forecast to decline at 5.1% per annum while its annual earnings are expected to grow at 15.3% per year. EPS is expected to grow by 12.8% per annum. Return on equity is forecast to be 20.4% in 3 years.
Wichtige Informationen
15.3%
Wachstumsrate der Gewinne
12.8%
EPS-Wachstumsrate
| Capital Markets Gewinnwachstum | 14.3% |
| Wachstumsrate der Einnahmen | -5.1% |
| Zukünftige Eigenkapitalrendite | 20.4% |
| Analystenabdeckung | Good |
| Zuletzt aktualisiert | 28 Oct 2024 |
Jüngste Aktualisierungen zum künftigen Wachstum
Keine Aktualisierungen
Recent updates
Gewinn- und Umsatzwachstumsprognosen
| Datum | Umsatz | Gewinne | Freier Cashflow | Bargeld aus operativen Tätigkeiten | Durchschn. Anz. Analysten |
|---|---|---|---|---|---|
| 12/31/2026 | 1,745 | 255 | N/A | 369 | 5 |
| 12/31/2025 | 1,610 | 227 | N/A | 328 | 6 |
| 12/31/2024 | 1,532 | 229 | N/A | 370 | 6 |
| 6/30/2024 | 2,082 | 163 | 365 | 382 | N/A |
| 3/31/2024 | 1,849 | 140 | N/A | N/A | N/A |
| 12/31/2023 | 1,882 | 141 | 723 | 735 | N/A |
| 9/30/2023 | 1,694 | 143 | N/A | N/A | N/A |
| 6/30/2023 | 1,818 | 139 | N/A | N/A | N/A |
| 3/31/2023 | 1,570 | 115 | N/A | N/A | N/A |
| 12/31/2022 | 1,010 | 98 | 216 | 226 | N/A |
| 12/31/2021 | 825 | 57 | 464 | 471 | N/A |
| 12/31/2020 | 758 | 44 | -51 | -46 | N/A |
| 12/31/2019 | 549 | 36 | -28 | -23 | N/A |
| 12/31/2018 | 384 | 10 | 128 | 130 | N/A |
| 12/31/2017 | 318 | 18 | N/A | -96 | N/A |
| 12/31/2016 | 328 | 20 | N/A | 30 | N/A |
| 12/31/2015 | 346 | 18 | N/A | 8 | N/A |
| 12/31/2014 | 368 | 18 | N/A | 22 | N/A |
| 12/31/2013 | 358 | -5 | N/A | -110 | N/A |
Analystenprognosen zum zukünftigen Wachstum
Einkommen vs. Sparrate: MRX's forecast earnings growth (15.3% per year) is above the savings rate (2.5%).
Ertrag vs. Markt: MRX's earnings (15.3% per year) are forecast to grow slower than the US market (15.4% per year).
Hohe Wachstumserträge: MRX's earnings are forecast to grow, but not significantly.
Einnahmen vs. Markt: MRX's revenue is expected to decline over the next 3 years (-5.1% per year).
Hohe Wachstumseinnahmen: MRX's revenue is forecast to decline over the next 3 years (-5.1% per year).
Wachstumsprognosen für den Gewinn je Aktie
Künftige Eigenkapitalrendite
Künftige Eigenkapitalrendite: MRX's Return on Equity is forecast to be high in 3 years time (20.4%)